PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
7 hedge funds and large institutions have $185K invested in PAVmed Inc. Series Z Warrant in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
22% less funds holding
Funds holding: 9 → 7 (-2)
50% less capital invested
Capital invested by funds: $369K → $185K (-$184K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$38.4K |
| 2 |
AC
Almitas Capital
Santa Monica,
California
|
-$27.8K |
| 3 |
LCS
Levin Capital Strategies
New York
|
-$12.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$6.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Warberg Asset Management
Winnetka,
Illinois
| $83K | -$38.4K | -60,984 | -27% |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $52K | -$6.7K | -10,647 | -9% |
|
|
AC
3
Almitas Capital
Santa Monica,
California
| $22K | -$27.8K | -44,196 | Closed |
|
|
LCS
4
Levin Capital Strategies
New York
| $21K | -$12.6K | -20,025 | -32% |
|
|
5
UBS Group
Zurich,
Switzerland
| $5K | +$3.06K | +4,859 | +98% |
|
6
Morgan Stanley
New York
| $1K | – | – | – |
|
7
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | – | – | – |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10K | -12,765 | Closed |
|
PAVMZ Hedge Fund Activity: Q2 2022 in Review
7 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q2 2022, worth a combined $185K — down 50% from $369K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PAVMZ and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $3.06K. The largest seller was Warberg Asset Management, cutting an estimated $38.4K.
- 7 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q2 2022, down from 9 in Q1 2022.
- Funds reported $185K of PAVmed Inc. Series Z Warrant stock for Q2 2022, down 50% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q2 2022 and 2 closed out, a net change of -2 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q2 2022 was UBS Group, an estimated $3.06K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q2 2022 was Warberg Asset Management, an estimated $38.4K sold.
Based on aggregated 13F filings for Q2 2022.